| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 789 | 560 | 273 | 792 | 1.734 | 4.310 | 6.084 | 6.712 | 8.649 | 9.605 |
| Total Income - EUR | 822 | 560 | 274 | 792 | 1.740 | 4.310 | 6.093 | 6.723 | 8.681 | 9.605 |
| Total Expenses - EUR | 2.309 | 950 | 89 | 169 | 149 | 0 | 8.979 | 7.563 | 10.220 | 12.912 |
| Gross Profit/Loss - EUR | -1.487 | -389 | 185 | 623 | 1.591 | 4.310 | -2.886 | -841 | -1.539 | -3.307 |
| Net Profit/Loss - EUR | -1.487 | -389 | 185 | 600 | 1.538 | 4.185 | -2.947 | -892 | -1.539 | -3.307 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Sante Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 551 | 0 | 0 | 0 | 0 | 0 | 714 | 516 | 4.659 | 11.818 |
| Current Assets | 191 | 214 | 415 | 1.062 | 2.000 | 608 | 800 | 3.346 | 2.349 | 1.877 |
| Inventories | 172 | 171 | 168 | 165 | 161 | 158 | 155 | 155 | 0 | 201 |
| Receivables | 2 | 2 | 2 | 2 | 448 | 440 | 430 | 431 | 428 | 1.482 |
| Cash | 17 | 41 | 245 | 896 | 1.391 | 10 | 215 | 2.760 | 1.921 | 194 |
| Shareholders Funds | -7.351 | -7.665 | -7.351 | -6.616 | -4.950 | -671 | -3.603 | -4.506 | -6.031 | -9.304 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.092 | 7.879 | 7.765 | 7.679 | 6.950 | 1.279 | 5.117 | 8.368 | 13.181 | 23.142 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Bio Sante Consult Srl